B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Signaling by NOTCH1 HD Domain Mutants in Cancer

REACTOME PATHWAY
Reactome: R-HSA-26912302 genes5 compounds

The Signaling by NOTCH1 HD Domain Mutants in Cancer pathway (Reactome ID: R-HSA-2691230) involves 2 genes and is affected by 5 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

ADAM10ADAM17

Compounds Affecting Signaling by NOTCH1 HD Domain Mutants in Cancer

#CompoundTargets HitStudies
1Bisphenol A-Glycidyl Methacrylate197
2Kaempferols300
3Progesterone299
4Hexachlorophene300
5Prednisolone1,000

About the Signaling by NOTCH1 HD Domain Mutants in Cancer Pathway

The Signaling by NOTCH1 HD Domain Mutants in Cancer pathway is catalogued in Reactome (ID: R-HSA-2691230) and involves 2 genes. In the BiohacksAI corpus, 5 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include ADAM10, ADAM17.